Seres Therapeutics (MCRB)

• Market cap: $82.3M
• 1 day: 0%
• 5 days: -4.67%
• 1 month: -0.92%
• 3 months: -46.64%
• 6 months: -56.45%
• Year to date: -43.37%
• 1 year: -35.34%
• 5 years: -97.92%
• 10 years: -98.57%
• Sector: Healthcare
• Industry: Biotechnology

About: Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.

Employees: 66